(MENAFN- GlobeNewsWire - Nasdaq) Opportunities span novel drugs, cosmetics and food testing. Key trends include AI risk assessment, integrated platforms, high-throughput screening, in vitro assays, omics and modeling.Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE) -- "ADME Toxicology Testing Market Report 2026" has been added to ResearchAndMarkets.com's offering.
ADME Toxicology Testing Market to Reach $20.25 Billion by 2030 as Novel Drug Development Accelerates
The global ADME toxicology testing market is experiencing rapid growth as pharmaceutical companies increase research and development activity and prioritize drug safety. The market is projected to grow from $11.5 billion in 2025 to $12.83 billion in 2026, representing a compound annual growth rate (CAGR) of 11.6%.
Historic market growth has been supported by greater regulatory emphasis on drug safety, expanding pharmaceutical research initiatives, and increasing adoption of liquid chromatography-mass spectrometry (LC-MS) and high-performance liquid chromatography (HPLC) instruments. The market has also evolved amid the limited availability of automated ADME testing systems and the continued use of traditional biochemical assays.
The ADME toxicology testing market is forecast to reach $20.25 billion by 2030, expanding at a CAGR of 12.1%. Key growth drivers include the development of integrated ADME testing platforms, rising use of omics and molecular imaging technologies, increased investment in predictive toxicology software, and wider adoption of ADME testing across the cosmetics and food industries. Artificial intelligence-driven risk assessment solutions are also expected to improve testing efficiency and support more informed drug development decisions.
Major ADME toxicology testing market trends include the growing adoption of high-throughput screening instruments, increased use of cell-based and in vitro assays, and rising demand for omics-based toxicology technologies. Pharmaceutical developers are also integrating simulation and modeling software into risk assessment workflows to improve the prediction of drug behavior, identify toxicity concerns earlier, and reduce the risk of costly late-stage failures.
Increasing demand for novel drugs is a major factor driving market expansion. ADME toxicology testing plays a critical role in drug development by evaluating the safety profile and potential toxic effects of new therapeutic candidates. In January 2024, the Center for Drug Evaluation and Research, a division of the U.S. Food and Drug Administration, reported that it approved 55 novel drugs during 2023. Of these approvals, 20 drugs, or 36%, were classified as first-in-class. This represented a notable increase from the 37 novel drugs approved in 2022 and highlighted the growing need for effective preclinical safety and toxicology testing.
Expansion of the pharmaceutical industry is also strengthening demand for ADME toxicology testing services and technologies. These assessments help researchers evaluate the absorption, distribution, metabolism, excretion, and potential toxicity of drug candidates. The resulting data supports candidate selection, preclinical development, regulatory submissions, and decisions regarding clinical advancement.
According to the European Federation of Pharmaceutical Industries and Associations, total pharmaceutical production in Europe reached €390.0 billion ($422.8 billion) in 2023, compared with €363.3 billion ($393.9 billion) in 2022. Continued pharmaceutical manufacturing growth, combined with sustained investment in drug discovery and development, is expected to increase demand for advanced ADME testing instruments, assays, software, and related services.
Technology providers are responding by introducing digital platforms that simplify access to ADME-Tox services. In October 2023, Germany-based biotechnology company Evotec SE launched the Cyprotex e-Store, an e-commerce platform offering online access to its ADME-Tox service portfolio. Registered users can review protocols and pricing, order services, monitor project progress, and place repeat orders. The platform is designed to streamline procurement, shorten lead times, and accelerate the delivery of data needed for drug development programs.
North America was the largest region in the ADME toxicology testing market in 2025, supported by its established pharmaceutical and biotechnology industries, advanced research infrastructure, and strong focus on regulatory compliance. Asia-Pacific is expected to be the fastest-growing region during the forecast period as drug development, contract research, and life sciences investment continue to expand. The geographic market includes Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
Markets Covered:
1) By Product Type: Instruments; Software Solutions; Assays Systems; Reagents; Other Product Types
2) By Method: Cellular Assay; Biochemical Assay; In Silica; Ex-Vivo
3) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology; Other Technologies
4) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications
5) By End-User: Cosmetics And Household Products; Pharmaceutical Industry; Animal Industry; Food Industry; Other End Users
Subsegments:
1) By Instruments: High-Throughput Screening Instruments; LC-MS Or MS (Liquid Chromatography-Mass Spectrometry); HPLC (High-Performance Liquid Chromatography); Automated Workstations
2) By Software Solutions: Data Management Software; Simulation And Modeling Software; Risk Assessment Software
3) By Assay Systems: Cell-Based Assays; In Vitro Assays; Bioanalytical Assays
4) By Reagents: Biochemicals; Buffer Solutions; Culture Media
5) By Other Products: Kits And Consumables; Analytical Standards
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment